Validated LC-MS/MS method for quantitation of total and free mycophenolic acid concentration and its application to a pharmacokinetic study in pediatric renal transplant recipients.
暂无分享,去创建一个
Jun Yu Li | G. Zhong | Pan Chen | Jingjie Li | Long-shan Liu | Q. Fu | Changxi Wang | Chenglin Wu | Huanxi Zhang | Jun Li | Yifan Zheng | Xiao Chen | Yan Liu | Longshan Liu | Jing-jie Li
[1] L. Renders,et al. Simultaneous Determination of Protein-Unbound Cyclosporine A and Mycophenolic Acid in Kidney Transplant Patients Using Liquid Chromatography–Tandem Mass Spectrometry , 2017, Therapeutic drug monitoring.
[2] P. Kunicki,et al. Free mycophenolic acid determination in human plasma ultrafiltrate by a validated liquid chromatography-tandem mass spectrometry method. , 2017, Biomedical chromatography : BMC.
[3] I. Yano,et al. Pharmacokinetics and pharmacodynamics of mycophenolic acid in Nagase analbuminemic rats: Evaluation of protein binding effects using the modeling and simulation approach. , 2015, Drug metabolism and pharmacokinetics.
[4] S. Masuda,et al. Sensitive and validated LC-MS/MS methods to evaluate mycophenolic acid pharmacokinetics and pharmacodynamics in hematopoietic stem cell transplant patients. , 2015, Biomedical chromatography : BMC.
[5] P. Kunicki,et al. A Comparison of the Immunochemical Methods, PETINIA and EMIT, With That of HPLC-UV for the Routine Monitoring of Mycophenolic Acid in Heart Transplant Patients , 2015, Therapeutic drug monitoring.
[6] A. Vinks,et al. Effects of Unbound Mycophenolic Acid on Inosine Monophosphate Dehydrogenase Inhibition in Pediatric Kidney Transplant Patients , 2014, Therapeutic drug monitoring.
[7] M. Pirmohamed,et al. Paediatric use of mycophenolate mofetil , 2013, British journal of clinical pharmacology.
[8] C. Guillemette,et al. A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for monitoring drug exposure in hematopoietic stem cell transplant recipients. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[9] P. Marquet,et al. Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure. , 2011, Transplantation reviews.
[10] L. Weber,et al. Pediatric aspects of therapeutic drug monitoring of mycophenolic acid in renal transplantation. , 2011, Transplantation reviews.
[11] A. Domínguez-Gil,et al. Modification of the EMIT immunoassay for the measurement of unbound mycophenolic acid in plasma. , 2011, Clinical biochemistry.
[12] K. Heinig,et al. Determination of mycophenolic acid and its phenyl glucuronide in human plasma, ultrafiltrate, blood, DBS and dried plasma spots. , 2010, Bioanalysis.
[13] B. Tönshoff,et al. Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation. , 2010, Clinical journal of the American Society of Nephrology : CJASN.
[14] M. L. Howard,et al. Plasma protein binding in drug discovery and development. , 2010, Combinatorial chemistry & high throughput screening.
[15] L. Shaw,et al. High-Performance Liquid Chromatography-Mass Spectroscopy/Mass Spectroscopy Method for Simultaneous Quantification of Total or Free Fraction of Mycophenolic Acid and its Glucuronide Metabolites , 2009, Therapeutic drug monitoring.
[16] Yu Fan,et al. Determination of total, free and saliva mycophenolic acid with a LC-MS/MS method: application to pharmacokinetic study in healthy volunteers and renal transplant patients. , 2009, Journal of pharmaceutical and biomedical analysis.
[17] L. Shaw,et al. Pharmacokinetic Modelling of the Plasma Protein Binding of Mycophenolic Acid in Renal Transplant Recipients , 2009, Clinical pharmacokinetics.
[18] Susan L Furth,et al. New equations to estimate GFR in children with CKD. , 2009, Journal of the American Society of Nephrology : JASN.
[19] C. Guillemette,et al. Sensitive high-performance liquid chromatography-tandem mass spectrometry method for quantitative analysis of mycophenolic acid and its glucuronide metabolites in human plasma and urine. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[20] Jiayin Huang,et al. Prediction of Unbound Mycophenolic Acid Concentrations in Patients After Hematopoietic Cell Transplantation , 2007, Therapeutic drug monitoring.
[21] M. Pescovitz,et al. Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: a population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients. , 2006, Journal of the American Society of Nephrology : JASN.
[22] M. Zhong,et al. Quantification of total and free mycophenolic acid in human plasma by liquid chromatography with fluorescence detection. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[23] David W. Johnson,et al. Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant. , 2005, British journal of clinical pharmacology.
[24] D. Holt,et al. Determination of total mycophenolic acid and its glucuronide metabolite using liquid chromatography with ultraviolet detection and unbound mycophenolic acid using tandem mass spectrometry. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[25] David W. Johnson,et al. Free Mycophenolic Acid Should Be Monitored in Renal Transplant Recipients with Hypoalbuminemia , 2004, Therapeutic drug monitoring.
[26] David W. Johnson,et al. Quantification of free mycophenolic acid and its glucuronide metabolite in human plasma by liquid-chromatography using mass spectrometric and ultraviolet absorbance detection. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[27] Susan M Abdel-Rahman,et al. Developmental pharmacology--drug disposition, action, and therapy in infants and children. , 2003, The New England journal of medicine.
[28] L. Shaw,et al. Mycophenolic Acid Pharmacodynamics and Pharmacokinetics Provide a Basis for Rational Monitoring Strategies , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[29] R. J. Dumont,et al. Pharmacokinetics and Protein Binding of Mycophenolic Acid in Stable Lung Transplant Recipients , 2002, Therapeutic drug monitoring.
[30] L. Benet,et al. Changes in plasma protein binding have little clinical relevance , 2002, Clinical pharmacology and therapeutics.
[31] L. Weber,et al. The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic Acid in pediatric renal transplant recipients: a report of the german study group on mycophenolate mofetil therapy. , 2002, Journal of the American Society of Nephrology : JASN.
[32] S. Tett,et al. Quantification of free mycophenolic acid by high-performance liquid chromatography-atmospheric pressure chemical ionisation tandem mass spectrometry. , 2000, Journal of chromatography. B, Biomedical sciences and applications.
[33] L. Weber,et al. Pharmacokinetics of mycophenolic acid (MPA) and determinants of MPA free fraction in pediatric and adult renal transplant recipients. German Study group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients. , 1998, Journal of the American Society of Nephrology : JASN.
[34] A. Nicholls,et al. Clinical Pharmacokinetics of Mycophenolate Mofetil , 1998, Clinical pharmacokinetics.
[35] S. Swan,et al. The pharmacokinetics of a single oral dose of mycophenolate mofetil in patients with varying degrees of renal function , 1998, Clinical pharmacology and therapeutics.
[36] L. Shaw,et al. Mycophenolic acid binding to human serum albumin: characterization and relation to pharmacodynamics. , 1995, Clinical chemistry.
[37] T. Franklin,et al. The inhibition of nucleic acid synthesis by mycophenolic acid. , 1969, The Biochemical journal.
[38] A. Dasgupta. Therapeutic Drug Monitoring of Mycophenolic Acid. , 2016, Advances in clinical chemistry.
[39] Peter Shaw,et al. HPLC-UV assay for monitoring total and unbound mycophenolic acid concentrations in children. , 2009, Biomedical chromatography : BMC.
[40] C. Staatz,et al. Clinical Pharmacokinetics and Pharmacodynamics of Mycophenolate in Solid Organ Transplant Recipients , 2007, Clinical pharmacokinetics.
[41] V. Armstrong,et al. Validation of a rapid and sensitive liquid chromatography-tandem mass spectrometry method for free and total mycophenolic acid. , 2004, Clinical chemistry.